News Sentiment

ADMA sentiment intelligence

ADMA Biologics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 32 Cautious news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 8.31 Week of 19 Jun 2026
Weighted tone 32/100

Cautious news tone

Market reaction Bad news being absorbed

Cautious headlines are being absorbed by price, which can signal underlying demand.

Primary event Regulatory and legal

80/100 classification confidence.

Company focus 52

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+1.2% over one week, +0.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

ADMA Deadline Alert: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. (ADMA) Investors of Securities Class Action Deadline on August 10, 2026

Market Reaction

Bad news being absorbed

80/100 confidence

Cautious headlines are being absorbed by price, which can signal underlying demand.

Primary event Regulatory and legal 80/100 classification
One-week reaction 1.2% Price digesting
Trend fit Trend inactive 0.8% over four weeks
Fair value -34.6% Below fair value
Caution agrees with inactive trend

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 24
Negative 30

Relevance

Why the article matched

Direct first
Direct company coverage 52
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
GlobeNewswire 14
Market source 10
simplywall.st 7
PR Newswire 5
ACCESS Newswire 3
Intellectia AI 3
Insider Monkey 3
Stock Titan 2

Event Lens

What the news is about

Classified themes
Regulatory and legal 33
Earnings 13
Market update 10
Guidance 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-59 of 59